Antimicrobianos y periodonto: manejo médico por el odontólogo general

Leslie Alzamora; Luis Carlos  Julio Narváez; Luis David Julio Alzamora

doi:10.16925/2357-4607.2021.02.06

Antimicrobianos e periodonto : manejo médico pelo dentista geral

Artículos de revisión

https://doi.org/10.16925/2357-4607.2021.02.06

Leslie Alzamora Ver Biografía

Corporación Universitaria Rafael Núñez

Luis Carlos Julio Narváez Ver Biografía

Universidad de Cartagena

Luis David Julio Alzamora Ver Biografía

Universidad del Sinú

As infecções odontogênicas (OI) estão relacionadas ao envolvimento da polpa dentária e à doença periodontal, são polimicrobianas, mas predominam os anaeróbios estritos. Além da drenagem ou do tratamento cirúrgico, são utilizados antimicrobianos que diminuem o tempo de resolução e favorecem os resultados predominantemente em termos de redução na profundidade da sondagem (DP) e ganho no nível de inserção. Os antimicrobianos mais comumente usados são beta-lactâmicos combinados com inibidor de betalactamase, nitroimidazol, metronidazol, azitromicina, entre macrolídeos, lincosaminas, principalmente clindamicina e quinolonas com maior sucesso moxifloxacino. Vários regimes desses antimicrobianos foram usados para determinar a não inferioridade na maioria, mas foram encontradas vantagens específicas com o uso de alguns como o menor tempo de terapia, a maior eficácia no caso do aparecimento de resistência bacteriana e efeitos mais baixos secundário.

Palavras-chave: infecções odontogênicas, periodontite, antimicrobianos

Kuriyama T, Williams DW, Yanagisawa M, Iwahara K, Shimizu C, Nakagawa K, Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics. Oral Microbiology Immunology. 2007; 22: 285–288.

Heim N, Faron A,Wiedemeyer V, Reich R. Microbiology and antibiotic sensitivity of head and neck space infections of odontogenic origin. Differences in inpatient and outpatient manage-ment. J Craniomaxillofac Surg. 2017; 45(10):1731-1735. doi: 10.1016/j.jcms.2017.07.013.

Keswani ES, Venkateshwar G, Odontogenic Maxillofacial Space Infections: A 5-Year Retrospective Review in Navi Mumbai. J Maxillofac Oral Surg. 2019; 18 (3):345-353.

Tent PA, Juncar RI, Onisor F, Bran S, Harangus A, Juncar M. The pathogenic microbial flo-ra and its antibiotic susceptibility pattern in odontogenic infections.Drug Metab Rev. 2019; 51(3):340-355.

Flynn T. What are the antibiotics of choice for odontogenic infections, and how long should the treatment course last? Oral Maxillofac Surg Clin North Am. 2011; 23(4):519–36

Robles Raya P, Javierre Miranda A, Moreno Millán N,Mas CasalsA, Management of odontoge-nic infections in Primary Care: Antibiotic? Aten Primaria. 2017; 49 (10):611-618. doi: 10.1016/j.aprim.2017.05.003.

A. Shah, V. Ramola, and V. Nautiyal, Aerobic microbiology and culture sensitivity of head and neck space infection of odontogenic origin. National journal of maxillofacial surgery, 2016; 7 (1): 56–61.

Warnke PH, Becker ST; Springer I, et al. Penicillin compared with other advanced broad spec-trum antibiotics regarding antibacterial activity against oral pathogens isolated from odon-togenic abscesses. J Craniomaxillofac Surg. 2008; 36(8):462–7.

Liau I, Han J, Bayetto K, May B, Goss A,Sambrook P, Cheng A. Antibiotic resistance in seve-re odontogenic infections of the South Australian population: a 9-year retrospective audit. Australian Dental Journal. 2018; 63: 187–192

Teoh L, Cheung MC, Dashper S, James R, McCullough MJ. Oral Antibiotic for Empirical Management of Acute Dentoalveolar Infections-A Systematic Review.Antibiotics (Basel). 2021; 10(3):240. doi: 10.3390/antibiotics10030240.

Keine KC, Kuga MC, Pereira KF, Diniz AC, Tonetto MR, Galoza MO, Magro MG, de Barros YB, Bandéca MC, de Andrade MF. Differential Diagnosis and Treatment Proposal for Acute Endodontic Infection. J Contemp Dent Pract. 2015; 16(12):977-83.

Weise H, Naros A, Weise C, Reinert S, Hoefert S. Severe odontogenic infections with septic progress - a constant and increasing challenge: a retrospective análisis. BMC Oral Health. 2019; 19(1):173. doi: 10.1186/s12903-019-0866-6.

Greenstein G, Greenstein B., Clinical management of acute orofacial infections. Compend Contin. Educ Dent.2015; 36(2):96-103; 104.

Taub D, Yampolsky A, Diecidue R, Gold L. Controversies in the Management of Oral and Maxillofacial Infections.Oral Maxillofac Surg Clin North Am. 2017; 29(4):465-473. doi: 10.1016/j.coms.2017.06.004.

Kosko J, et al. Retropharyngeal and parapharyngeal abscesses: Factors in medical manage-ment failure.Ear Nose Throat J. 2017; 96(1):E12-E15.

Farmahan S, Tuopar D, Ameerally PJ, Kotecha R, Sisodia B. Microbiological examination and antibiotic sensitivity of infections in the head and neck. Has anything changed?Br J Oral Maxillofac Surg. 2014; 52(7):632-5. doi: 10.1016/j.bjoms.2014.02.028.

Haque M, Sartelli M, Haque SZ. Dental Infection and Resistance-Global Health Consequences.Dent J (Basel). 2019; 7(1):22. doi: 10.3390/dj7010022.

Farmahan S, Tuopar D, Ameerally PJ. The clinical relevance of microbiology specimens in head and neck space infections of odontogenic origin. Br J Oral Maxillofac Surg. 2014; 52(7):629-31.

Ferneini EM, Goldberg MH.J Oral Maxillofac Surg. Management of Oral and Maxillofacial Infections.2018; 76 (3):469-473. doi: 10.1016/j.joms.2017.11.032.

Sato FR, Hajala FA, Freire Filho FW, et al. Eight-year retrospective study of odontogenic origin infections in a postgraduation program on oral and maxillofacial surgery. J Oral Maxillofac Surg. 2009; 67:1-10.

Bali RK, Sharma P, Gaba S, Kaur A, Ghanghas P. A review of complications of odontogenic in-fections. Natl J Maxillofac Surg. 2015; 6(2):136-43.

Plum AW, Mortelliti AJ, Walsh RE. Microbial flora and antibiotic resistance in odonto-genic abscesses in Upstate New York.Ear Nose Throat J. 2018; 97(1-2):E27-E31. doi: 10.1177/0145561318097001-207.

Farmahan S, Tuopar D, Ameerally PJ. The clinical relevance of microbiology specimens inhead and neck space infections ofodontogenic origin.Br J Oral Maxillofac Surg. 2014; 52(7):629-31.

Bayetto K, Cheng A, Goss A. Dental abscess: A potential cause of death and morbidity.Aust J Gen Pract. 2020; 49(9):563-567. doi: 10.31128/AJGP-02-20-5254.

Bali RK, Sharma P, Gaba S, Kaur A, Ghanghas P. A review of complications of odontogenic infections.Natl J Maxillofac Surg. 2015; 6(2):136-43. doi: 10.4103/0975-5950.183867.

Gaber Hassanein A, Mohamed EEH, Hazem M, El Sayed AESM. Assessment of Prognosis in Odontogenic Descending Necrotizing Mediastinitis: A Longitudinal Retrospective Study.

Surg Infect. Larchmt. 2020; 21(8):709-715. doi: 10.1089/sur.2019.302.

Geng B, Wu X, Malhotra A. Septic cavernous sinus thrombosis-Case series and review of the literature.Clin Neurol Neurosurg. 2020; 197:106092. doi: 10.1016/j.clineuro.2020.106092.

Martınez-Martinez Luis, Calvo Jorge. Mecanismos de acción de los antimicrobianos. Enferm Infecc Microbiol Clin. 2009; 27(1):44–52.

Isla A, Canut A, Rodríguez-Gascón A, Labora A, Ardanza-Trevijano B, Solinís MA, Pedraz JL. Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stoma-tology. Enferm Infecc Microbiol Clin. 2005; 23(3):116-21.

Miyachiro MM, Contreras-Martel C, Dessen A. Penicillin-Binding Proteins (PBPs) and Bacterial Cell Wall Elongation Complexes. Subcell Biochem. 2019; 93:273-289. doi: 10.1007/978-3-030-28151-98.

Ece Barça, Emine Çifcibaşı, Serdar Çintan. Adjunctive use of antibiotics in periodontal thera-py. J Istanbul Univ Fac Dent. 2015;49(3):55-62.

Eick S, Nydegger J, Bürgin W, Salvi GE, Sculean A, Ramseier C. Microbiological analysis and the outcomes of periodontal treatment with or without adjunctive systemic antibiotics-a re-trospective study. Clin Oral Investig. 2018; 22(9):3031-3041.

Spížek J, Řezanka T. Lincosamides: Chemical structure, biosynthesis, mechanism of ac-tion, resistance, and applications.. Biochem Pharmacol. 2017; 133:20-28. doi: 10.1016/j.bcp.2016.12.001.

Bhagania M, Youseff W, Mehra P, Figueroa R. Treatment of odontogenic infections: An analy-sis of two antibiotic regimens.J Oral Biol Craniofac Res. 2018; 8(2):78-81. doi: 10.1016/j.jobcr.2018.04.006.

Workman AD, Granquist EJ, Adappa ND. Odontogenic sinusitis: developments in diagnosis, microbiology, and treatment.Curr Opin Otolaryngol Head Neck Surg. 2018; 26(1):27-33. doi: 10.1097/MOO.0000000000000430.

Orrett E. Ogle, Odontogenic Infections. Dent Clin N Am. 2017; 61:235–252.

Vázquez-Laslop N, Mankin AS. How Macrolide Antibiotics Work.Trends Biochem Sci. 2018; 43(9):668-684. doi: 10.1016/j.tibs.2018.06.011.

Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis. 2001; 32(Suppl 1):S9–S15.

Mombelli A, Almaghlouth A, Cionca N, Cancela J, Courvoisier DS, Giannopoulou C. Microbiologic Response to Periodontal Therapy and Multivariable Prediction of Clinical Outcome. J Periodontol. 2017; 88(12):1253-1267.

Zandbergen D, Slot DE, Niederman R, Van der Weijden FA.The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: a systematic review. BMC oral. 2016; 29:16-23

Ellison SJ. The role of phenoxymethylpenicillin, amoxicillin, metronidazole and clindamycin in the management of acute dentoalveolar abscesses.a review. Br Dent J. 2009; 206 (7):357-62.

Bush NG, Diez-Santos I, Abbott LR, Maxwell A. Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.Molecules. 2020; 25(23):5662. doi: 10.3390/molecules25235662.

Ardila CM, Bedoya-García JA. A multilevel analysis of a randomized clinical trial comparing adjunctive moxifloxacin versus amoxicillin/metronidazole for the treatment of aggressive pe-riodontitis..Dent Res J. 2021 Jun 22;18:44.

Holmes CJ, Pellecchia R. Antimicrobial Therapy in Management of Odontogenic Infections in General Dentistry. Dent Clin North Am. 2016; 60(2):497-507.

Tancawan A, Pato M. Amoxicillin/Clavulanic Acid for the Treatment of Odontogenic Infections: A Randomised Study Comparing Efficacy and Tolerability versus Clindamycin. Int J Dent.2015; 472470. doi: 10.1155/2015/472470.

Cachovan G,. Boger R, Giersdorf I,Olaf Hallier, Streichert T, Comparative Efficacy And Safety Of Moxifloxacin And Clindamycin In The Treatment Of Odontogenic Abscesses And Inflammatory Infiltrates: A Phase II, Double-Blind, Randomized Trial. Antimicrobial Agents And Chemotherapy. 2011; 55(3):1142–1147.

Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. J Periodontol. 2009; 80(3):364-71.

Ardila C, Guzgam I. Benefits of adjunctive moxifloxacin in generalized aggressive periodon-titis: a subgroup analyses in Aggregatibacter actinomycetemcomitans-positive/negative pa-tients from a clinical trial. Journal of Investigative and Clinical Dentistry. 2015: 1–8.

Rabelo CC, Feres M, Gonc_alves C, Figueiredo. Systemic antibiotics in the treatment of ag-gressive periodontitis. A systematic review and a Bayesian Network meta-analysis. J Clin Periodontol. 2015; 42: 647–657.

Borges I, Faveri M, Figueiredo LC, Duarte PM, Retamal-Valdes B, Montenegro SCL, Feres M. Different antibiotic protocols in the treatment of severe chronic periodontitis: A 1-year ran-domized trial. J Clin Periodontol. 2017; 44:822–832.

Khan A, Sharma D, Management of Peri-Implant Diseases: A Survey of Australian Periodontists. Dent J (Basel). 2020; 8(3):100. doi: 10.3390/dj8030100.

Antimicrobianos e periodonto: manejo médico pelo dentista geral. (2021). Revista Nacional De Odontología, 17(2), 1-19. https://doi.org/10.16925/2357-4607.2021.02.06

Baixar Citação

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

O autor deve declarar que seu trabalho é original e inédito e que não foi enviado à avaliação simultânea para sua publicação por outro meio. Além disso, deve garantir que não tem impedimentos de nenhuma natureza para a concessão dos direitos previstos no contrato.

O autor se compromete a esperar o parecer da Revista Nacional de Odontología antes de considerar sua apresentação a outro meio; caso a resposta de publicação seja positiva, compromete-se em responder por qualquer ação de reivindicação, plágio ou outro tipo de reclamação que possa ocorrer por parte de terceiros.

Ainda, deve declarar que, como autor ou coautor, está completamente de acordo com os conteúdos apresentados no trabalho e ceder todos os direitos patrimoniais, isto é, sua reprodução, comunicação pública, distribuição, divulgação, transformação e demais formas de utilização da obra por qualquer meio ou procedimento, pelo termo de sua proteção legal e em todos os países do mundo, ao Fundo Editorial da Universidad Cooperativa de Colombia, de maneira gratuita e sem compensação monetária.

Edição

v. 17 n. 2 (2021)

Publicado

2021-07-12

Downloads

PDF (Espanhol)

Métricas

Carregando Métricas ...

https://plu.mx/plum/a/?doi=10.16925/2357-4607.2021.02.06